Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 14 March 2022 to Question 136495 on Coronavirus: Health Services, for what reason no money has been allocated to research to improve diagnosis and treatment of covid-19 vaccine damage other than for blood clotting with low platelets; and if he will make a statement.

The Department commissions research through the National Institute for Health Research (NIHR). The NIHR has allocated approximately £117,509,455 for COVID-19 vaccine research, including monitoring of adverse reactions and trials of the Pfizer, Novavax and Janssen vaccines where safety and efficacy was the primary focus.

The NIHR welcomes funding applications for research into any aspect of human health, including the safety of COVID-19 vaccines.